Clinical Trials Browser

Phase 1 × Active not recruiting × sotigalimab × Clear all

NCT04495257 2025-10-30

A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)

Phase 1 Active not recruiting

Carcinoma, Renal Cell